the objectives, documentation requirements, roles, and inspection expectations associated with these systems.

Step 1: Understanding Regulatory Frameworks

The first step in developing a Combined & Companion QMS is to understand the regulatory frameworks that govern medical devices and combination products. In the United States, the FDA regulates these products under the Federal Food, Drug, and Cosmetic Act. In the EU, the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) apply, while the UK has its own regulatory framework post-Brexit.

Objectives: The primary objective is to ensure that the QMS aligns with the regulatory requirements applicable to your products. This includes understanding the specific requirements for design control, risk management, and post-market surveillance.

Documentation: Essential documents include regulatory guidelines, product classification information, and relevant ISO standards such as ISO 13485 for medical devices.

Roles: Quality managers must collaborate with regulatory affairs teams to ensure compliance. This may involve training staff on regulatory expectations and conducting gap analyses against current practices.

Inspection Expectations: During inspections, regulators will review documentation to ensure that the QMS is compliant with applicable regulations. They will assess whether the organization has a thorough understanding of the regulatory landscape.

Step 2: Establishing a Quality Management Framework

Once the regulatory landscape is understood, the next step is to establish a robust quality management framework. This framework should encompass all aspects of product development, manufacturing, and post-market activities.

Objectives: The goal is to create a comprehensive QMS that integrates quality planning, quality control, quality assurance, and quality improvement processes.

Documentation: Key documents include the Quality Manual, Standard Operating Procedures (SOPs), and work instructions. These documents should clearly outline processes and responsibilities.

Roles: Quality managers are responsible for the development and maintenance of the QMS documentation. They should also ensure that all employees are trained on these processes.

Inspection Expectations: Inspectors will evaluate the adequacy of the QMS framework, including the effectiveness of SOPs and the training records of personnel involved in quality-related activities.

Step 3: Implementing Risk Management Practices

Risk management is a critical component of a Combined & Companion QMS. It involves identifying, assessing, and mitigating risks associated with medical devices and combination products.

Objectives: The objective is to ensure that risks are systematically managed throughout the product lifecycle, from design to post-market surveillance.

Documentation: Risk management documentation should include risk assessments, risk management plans, and reports on risk mitigation activities. ISO 14971 provides guidance on risk management for medical devices.

Roles: The risk management team, often led by a quality manager, should include representatives from design, manufacturing, and regulatory affairs to ensure a comprehensive approach.

Inspection Expectations: Inspectors will review risk management documentation to verify that risks have been appropriately identified and mitigated. They will also assess the effectiveness of the risk management process in practice.

Step 4: Ensuring Design Control Compliance

Design control is a fundamental aspect of the QMS for medical devices and combination products. It ensures that products are designed to meet user needs and regulatory requirements.

Objectives: The objective is to establish a systematic approach to design and development that includes planning, inputs, outputs, verification, validation, and design transfer.

Documentation: Documentation should include Design History Files (DHF), Design Control Plans, and verification and validation reports. The FDA provides guidance on design controls in 21 CFR 820.30.

Roles: Design engineers, quality managers, and regulatory affairs professionals must collaborate to ensure that design controls are effectively implemented.

Inspection Expectations: Inspectors will examine the DHF and related documentation to assess compliance with design control requirements. They will look for evidence of effective verification and validation activities.

Step 5: Implementing Effective Training Programs

Training is essential for ensuring that all personnel understand their roles within the QMS and are equipped to perform their tasks effectively.

Objectives: The objective is to create a training program that addresses the specific needs of employees involved in quality management, regulatory compliance, and product development.

Documentation: Training records should include training plans, attendance records, and assessments of employee competencies. Documentation should also outline the training curriculum and materials used.

Roles: Quality managers are responsible for developing and implementing training programs. They should work with department heads to identify training needs and ensure that employees receive the necessary training.

Inspection Expectations: Inspectors will review training records to ensure that employees have received adequate training and that training programs are regularly updated to reflect changes in regulations and processes.

Step 6: Conducting Internal Audits

Internal audits are a critical component of a Combined & Companion QMS. They help organizations identify areas for improvement and ensure ongoing compliance with regulatory requirements.

Objectives: The objective is to systematically evaluate the effectiveness of the QMS and identify any non-conformities or areas for improvement.

Documentation: Audit documentation should include audit plans, checklists, findings, and corrective action reports. ISO 19011 provides guidance on auditing management systems.

Roles: Internal auditors, often trained quality professionals, should conduct audits independently to ensure objectivity. Quality managers should oversee the audit process and follow up on corrective actions.

Inspection Expectations: Inspectors will review internal audit reports to assess the effectiveness of the audit process and verify that corrective actions have been implemented for identified non-conformities.

Step 7: Managing Non-Conformities and CAPA

Managing non-conformities and implementing Corrective and Preventive Actions (CAPA) is vital for maintaining compliance and improving the QMS.

Objectives: The objective is to establish a systematic approach for identifying, investigating, and resolving non-conformities to prevent recurrence.

Documentation: CAPA documentation should include non-conformity reports, investigation findings, root cause analyses, and action plans. The FDA provides guidance on CAPA in 21 CFR 820.100.

Roles: Quality managers should lead the CAPA process, involving cross-functional teams to ensure comprehensive investigations and effective solutions.

Inspection Expectations: Inspectors will review CAPA documentation to assess the effectiveness of the process and ensure that appropriate actions have been taken to address identified issues.

Step 8: Continuous Improvement and Management Review

The final step in establishing a Combined & Companion QMS is to implement a continuous improvement process and conduct regular management reviews.

Objectives: The objective is to foster a culture of continuous improvement and ensure that the QMS remains effective and compliant with evolving regulations.

Documentation: Documentation should include management review meeting minutes, performance metrics, and improvement plans. ISO 9001 emphasizes the importance of continual improvement.

Roles: Quality managers should facilitate management reviews and ensure that relevant data is presented to leadership for decision-making.

Inspection Expectations: Inspectors will evaluate the effectiveness of the continuous improvement process and the outcomes of management reviews to ensure that the QMS is responsive to changing needs.

Conclusion

Establishing a Combined & Companion QMS for medical devices and combination products is a complex but essential process for ensuring regulatory compliance and product quality. By following the steps outlined in this guide, quality managers, regulatory affairs professionals, and compliance experts can create a robust QMS that meets the expectations of the FDA, EMA, and ISO standards. The lessons learned from real inspections underscore the importance of thorough documentation, effective training, and a commitment to continuous improvement in maintaining compliance and enhancing product quality.